A Contemporary Framework Update for Today's School Nursing Landscape: Introducing the School Nursing Practice Framework™.

School nursing is a unique nursing specialty that benefits from a practice framework that aids school nurses in explaining and accomplishing their role. In 2016, the NASN debuted its Framework for 21st Century School Nursing Practice™, which has shaped school nursing practice as well as education, leadership, research, and collaboration with stakeholders. However, practice frameworks are not meant to remain the same indefinitely.

Medical-surgical nurses' EBP beliefs and competencies.

Background: The lack of evidence-based practice (EBP) knowledge and inability to implement EBP among nurses is a major barrier to quality nursing care. The literature shows that nurses highly value the use of EBP, however, they lack necessary EBP competencies. Although medical-surgical nurses were included in studies examining cross-sections of the nursing workforce, no studies exist specifically investigating their EBP beliefs and EBP competencies.

The combined effect of psychological and social capital in registered nurses experiencing second victimization: A structural equation model.

Purpose: This study examined the combined role psychological capital and social capital play in the severity of second victim syndrome experienced by registered nurses.

Design: This research study was an ex post facto, cross-sectional, non-experimental survey design. Data were collected from October to December 2018.

Continued investigator engagement: Reasons principal investigators conduct multiple FDA-regulated drug trials.

Background/aims: Numerous reasons have been identified for why U.S.-based principal investigators choose to not continue participating in FDA-regulated trials.

Improving and sustaining the site investigator community: Recommendations from the Clinical Trials Transformation Initiative.

The Clinical Trials Transformation Initiative (CTTI) Strengthening the Investigator Community Project was prompted by the need to understand the reasons for high rates of turnover among investigators who lead US Food and Administration-regulated clinical trials at research sites. Because investigator knowledge and experience directly affect the quality and ultimate success of clinical trials, investigator turnover has important implications for the research enterprise, as well as the patients and other stakeholders who depend on the outcomes of clinical research. The CTTI project team used findings from both quantitative and qualitative research activities, as well as input from an expert meeting with multiple stakeholders, to delineate key concerns faced by investigators and recommend practical, action-based solutions.

Trends in clinical trial investigator workforce and turnover: An analysis of the U.S. FDA 1572 BMIS database.

Background: High turnover rates among clinical trial investigators contribute to inefficiency, instability, and increased costs for the clinical research enterprise; however, factors contributing to investigator turnover have not been well characterized.

Methods: Using information from the U.S.

One and done: Reasons principal investigators conduct only one FDA-regulated drug trial.

Concerns have been raised over the high turnover rate for clinical investigators. Using the U.S.